Capital Adept
  • Politics
  • Investing
  • Stocks
  • Business
  • Politics
  • Investing
  • Stocks
  • Business

Capital Adept

Politics

Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

by admin April 16, 2025
April 16, 2025
Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

A top advisor to Defense Secretary Pete Hegseth was escorted out of the Pentagon on Tuesday and placed on administrative leave, according to a Defense Department official. 

Reuters first reported Caldwell had been placed on leave for an ‘unauthorized disclosure’ of information amid an investigation into Pentagon leaks. An official confirmed to Fox News Digital that Reuters’ reporting is accurate but declined to comment on an ongoing investigation. 

Caldwell previously worked at restraint-minded think tank Defense Priorities and Concerned Veterans for America, a group formerly led by Hegseth. A foreign policy realist, he has argued that the U.S. should dramatically reduce its footprint in Europe and pull out forces in Iraq and Syria. 

Last month, the Defense Department announced a probe into ‘recent unauthorized disclosures of national security information’ and said it planned to use polygraphs to determine the source of leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution.

Caldwell did not immediately reply to a request for comment. 

Caldwell’s closeness to the defense secretary was underscored in the unintentionally leaked Signal chat on Houthi strikes, where Hegseth named him as the Pentagon point of contact for the offensive campaign. 

This post appeared first on FOX NEWS

previous post
Soaring Medicare prescription drug prices targeted in Trump’s new executive order
next post
Trump directs agencies to follow Supreme Court rulings, as he continues to rein in administrative state

Related Posts

Republicans unveil key piece of shutdown puzzle in...

November 10, 2025

Trump announces 100% tariff on all foreign-produced movies:...

May 5, 2025

Supreme Court divided over state effort to defund...

April 3, 2025

Top 5 moments from Charlie Kirk’s memorial service...

September 22, 2025

Trump admin’s Signal leak shows ‘profound’ risk of...

March 31, 2025

Trump pardons Rudy Giuliani, Mark Meadows, Sidney Powell,...

November 10, 2025

Israel eliminates Houthi prime minister in Yemen airstrike...

August 31, 2025

23andMe bankruptcy prompts Cornyn-Grassley-Klobuchar bipartisan bill to protect...

May 23, 2025

AT&T gave Jack Smith then-House Speaker McCarthy’s personal...

November 20, 2025

Trump, Democrats locked in endless cycles of payback...

September 30, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Copper Price Update: Q1 2025 in Review

      April 14, 2025
    • 2

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 3

      The Best Five Sectors, #10

      March 14, 2025
    • 4

      Transform Your Investing Strategy: Uncover the 3 Game-Changing Rules

      March 14, 2025
    • 5

      DP Trading Room: Market Sell-Off

      March 14, 2025
    • 6

      5 Strong Stocks Defying the Bearish Market!

      March 14, 2025
    • 7

      Sector Rotation Warning: More Downside Ahead for US Markets?

      March 14, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 capitaladept.com | All Rights Reserved